Sagility India Limited’s Initial Public Offering to open on Tuesday, November 05, 2024...
Sagility India Limited’s Initial Public Offering to open on Tuesday, November 05, 2024, price band set at ₹28/- to ₹30/- per Equity Share
Photo: (L-R) Sarvabhouman Doraiswamy Srinivasan, Group Chief Financial Officer, Ramesh Gopalan, Managing Director and Group CEOMumbai, October 30, 2024: Sagility India Limited, provides technology-enabled business solutions and services to clients in the U.S. healthcare industry, has fixed the price band of ₹28/- to ₹30/- per Equity Share of face value ₹10/- each for its maiden initial public offer.
The Initial Public Offering (“IPO” or “Offer”) of the Company will open on Tuesday, November 05, 2024, for subscription and close on Thursday, November 07, 2024. Investors can bid for a minimum of 500 Equity Shares and in multiples of 500 Equity Shares thereafter.
The IPO is entirely an offer for sale of up to 702.20 million equity shares by Sagility B.V, the Promoter Selling Shareholder. The offer includes a discount of Rs 2 for eligible employees bidding in the employee reservation process.
Sagility India Limited is a pure-play healthcare focused services provider, and its clients include Payers (U.S. health insurance companies, which finance and reimburse the cost of health services) and Providers (primarily hospitals, physicians, and diagnostic and medical devices companies)
The Company services to Payers cater to various aspects of their operations including core benefits administration functions such as claims management, enrolment, benefits plan building, premium billing, credentialing, and provider data management and clinical functions such as utilization management, care management, and population health management.
Its services to Providers include revenue cycle management functions such as financial clearance, medical coding, billing, and accounts receivable follow-up services. Additionally, it also provides some of the services that it provides to Payers to pharmacy benefit managers (“PBMs”) that manage prescription drugs for Members (i.e., insured persons) under health insurance plans. It delivers the services leveraging its tools and platforms, as needed, through its capable talent pool from its five global service delivery locations in India, the Philippines, the U.S., Jamaica and Colombia.
In the Financial Year 2024, Sagility helped Payer clients process 105 million claims and manage over 75 million Member and Provider interactions. It has no listed comparable in India or abroad that cater to US Healthcare Enterprises
As of June 30, 2024, Sagility employed 35,858 people, with 60.52% being women. This was 33,575 people in June 30 2023.
Sagility India’s restated revenue from operations during the fiscal year 2024 increased 12.69% to Rs 4,753.56 crore from Rs 4,218.41 crore in the previous year, primarily due to growth in volumes from existing clients and addition of new SOWs during the Financial Year 2024. Profit after tax grew 58.99% from Rs 143.57 crore for the financial year 2023 to Rs 228.27 crore for the financial year 2024.
For the three months ended June 30, 2024, revenue from operations stood at Rs 1,223.33 crore and profit after tax stood at Rs 22.29 crore.
The offer is being made through the book-building process, wherein not less than 75% of the net offer shall be available for allocation on a proportionate basis to qualified institutional buyers, not more than 15% of the net offer shall be available for allocation to non-institutional investors, and
not more than 10% of the net offer shall be available for allocation to retail individual bidders.
ICICI Securities Limited, IIFL Securities Limited, Jefferies India Private Limited, J.P. Morgan India Private Limited are the book-running lead managers, and Link Intime India Private Limited is the registrar of the issue.
Notes for Reference:
Issue Size of the IPO based on the upper and lower end of the price band
Offer for sale (702,199,262 equity shares) | |
Lower Band (@ Rs 28) | Rs 1,966.16 crore |
Upper Band (@ Rs 30) | Rs 2,106.60 crore |
Comments
Post a Comment